Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Alpha Emitter Market, by Region, 2019-2027 (USD Billion)
1.2.2. Alpha Emitter Market, by Type of Radionuclide, 2019-2027 (USD Billion)
1.2.3. Alpha Emitter Market, by Medical Application, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Alpha Emitter Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Alpha Emitter Market Dynamics
3.1. Alpha Emitter Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing number of patients with cardiac and cancer ailments
3.1.1.2. Increased awareness about the potential benefits of targeted alpha therapy
3.1.2. Market Restraint
3.1.2.1. Stringent regulatory framework and reimbursement issues
3.1.3. Market Opportunities
3.1.3.1. Product launches
Chapter 4. Global Alpha Emitter Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Alpha Emitter Market, by Type of Radionuclide
5.1. Market Snapshot
5.2. Global Alpha Emitter Market by Type of Radionuclide, Performance - Potential Analysis
5.3. Global Alpha Emitter Market Estimates & Forecasts by Type of Radionuclide 2018-2027 (USD Billion)
5.4. Alpha Emitter Market , Sub Segment Analysis
5.4.1. Astatine (At-211)
5.4.2. Radium (Ra-223)
5.4.3. Actinium (Ac-225)
5.4.4. Lead (Pb-212)
5.4.5. Bismuth (Bi-212)
5.4.6. Other Type of Radionuclides
Chapter 6. Global Alpha Emitter Market, by Medical Application
6.1. Market Snapshot
6.2. Global Alpha Emitter Market by Medical application, Performance - Potential Analysis
6.3. Global Alpha Emitter Market Estimates & Forecasts by medical Application 2018-2027 (USD Billion)
6.4. Alpha Emitter Market , Sub Segment Analysis
6.4.1. Prostate Cancer
6.4.2. Bone Metastasis
6.4.3. Ovarian Cancer
6.4.4. Pancreatic Cancer
6.4.5. Endocrine Tumors
6.4.6. Other Medical Applications
Chapter 7. Global Alpha Emitter Market, Regional Analysis
7.1. Alpha Emitter Market , Regional Market Snapshot
7.2. North America Alpha Emitter Market
7.2.1. U.S. Alpha Emitter Market
7.2.1.1. Type of Radionuclide breakdown estimates & forecasts, 2018-2027
7.2.1.2. Medical Application breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Alpha Emitter Market
7.3. Europe Alpha Emitter Market Snapshot
7.3.1. U.K. Alpha Emitter Market
7.3.2. Germany Alpha Emitter Market
7.3.3. France Alpha Emitter Market
7.3.4. Spain Alpha Emitter Market
7.3.5. Italy Alpha Emitter Market
7.3.6. Rest of Europe Alpha Emitter Market
7.4. Asia-Pacific Alpha Emitter Market Snapshot
7.4.1. China Alpha Emitter Market
7.4.2. India Alpha Emitter Market
7.4.3. Japan Alpha Emitter Market
7.4.4. Australia Alpha Emitter Market
7.4.5. South Korea Alpha Emitter Market
7.4.6. Rest of Asia Pacific Alpha Emitter Market
7.5. Latin America Alpha Emitter Market Snapshot
7.5.1. Brazil Alpha Emitter Market
7.5.2. Mexico Alpha Emitter Market
7.6. Rest of The World Alpha Emitter Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Alpha Tau Medical Ltd
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Actinium Pharmaceutical Inc.
8.2.3. IBA Radiopharma Solutions
8.2.4. Telix Pharmaceuticals Ltd
8.2.5. Fusion Pharmaceuticals
8.2.6. RadioMedix Inc.
8.2.7. Bayer AG
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption